-
DE
PDRN (Polydeoxyribonucleotide) is a bioactive compound derived from salmon sperm DNA, widely used to promote tissue regeneration and wound healing.
Add as Preferred SourcePDRN (Polydeoxyribonucleotide) is a bioactive compound derived from salmon sperm DNA, widely used to promote tissue regeneration and wound healing.
PDRN, short for Polydeoxyribonucleotide, is a bioactive substance extracted from salmon sperm DNA. It consists of short DNA fragments and is used in medicine primarily to support tissue repair and wound healing. PDRN has found applications in dermatology, orthopedics, and ophthalmology.
PDRN exerts its effects through two main mechanisms:
Additionally, PDRN promotes collagen production and angiogenesis (the formation of new blood vessels), improving wound healing and tissue nourishment.
In dermatology, PDRN is used to treat chronic wounds, diabetic ulcers, burns, and skin injuries. It supports the regeneration of skin tissue and reduces scarring. In aesthetic medicine, PDRN is increasingly used for skin rejuvenation and the treatment of signs of skin aging.
In orthopedics, PDRN is administered as an intra-articular injection for joint conditions such as osteoarthritis. Studies indicate that PDRN has anti-inflammatory effects, may promote cartilage regeneration, and helps reduce joint pain. It is also used in the treatment of tendon and ligament injuries.
In ophthalmology, PDRN is being investigated and used to promote corneal regeneration and to treat dry eye syndrome and other ocular injuries.
PDRN is available in various forms:
The exact dosage depends on the indication and should always be determined by a qualified healthcare professional.
PDRN is generally considered well tolerated. As it is derived from natural DNA, it is biocompatible and degraded by the body. Possible side effects from injections include:
Individuals with a known allergy to fish products should inform their doctor before use, as PDRN is derived from salmon sperm.
Numerous preclinical and clinical studies support the regenerative properties of PDRN. The evidence is particularly promising for wound healing and osteoarthritis treatment, although further large-scale randomized controlled trials are still needed. PDRN is approved as a pharmaceutical drug in several countries, including South Korea and Italy.